May 13 2019 - SPY & QQQ Bust Through Support

Bonus Content Sponsored

Options Trading System With A 94.8% Win-Rate On Last 727 Trades

The key to being consistently profitable as a trader is to focus on high-probability trades. And in this powerful eBook by Dave Acquino, titled The Ultimate Income Trading System, you'll see exactly how Dave and so many of his students do just that. They make 4%, 5% or 6% on each trade and they're in the trade for just 11 hours.

CLICK HERE for instant access.

Turn $1,000 into $1.57 Million -- with "Holy Grail of Medicine"

On September 10, 2018, a tiny biotech firm won a patent on a new treatment that can "Cut & Paste" any disease from your body. The Nobel Prize Committee called it "The Holy Grail of Medicine." This under-the-radar company is not yet a household name.

Our research proves that anyone who gets in now could turn $1,000 into $1.57 Million >>>

First-time "stock flippers" making $30,000 a month

Ever heard of Stock Flipping? Most Americans haven't. It's a growing movement of people who are fed up with the false promises of get-rich-quick real estate investing. And many of them are now making $15,000 to $30,000 a month with less than an hour of work per week. Want to know how they do it?

Click here for the free session.

Buffett Goes "All In" on Tech???

Buffett is notoriously "anti technology."

Which is why this Wall Street Legend's recent discover is so shocking:

21 of Buffett's 25 current favorite companies are going "all in" one hot new technology...

To the tune of $1.7 billion!

...After decades of being anti-tech...what is making Buffett go all in now?

And what is this new technology that America's biggest companies are in a race to implement?

Click here for full details...

Small Biotech Firm Stuns World

On November 16, 2016 a small biotech used a radical new treatment to restore blindness in mice. CBS News called this breakthrough "the most consequential discovery in biomedicine this century."

Investors who get in early are set to earn 46,751% returns.

As seen on...